Notice_of_Intent-NIDDK-04424.docx

Hospital and Laboratory Support Division Office of Logistics and Operations (OLAO) Office of Acquisition and Logistics Management (OALM)

Title: Luminex™ xMAP™ INTELLIFLEX System

Presolicitation

Synopsis No. 75N98026Q00189

SYNOPSIS

General Information

Contracting Office Address

National Institutes of Health (NIH), Office of the Director (OD) Office of Logistics and Operations (OLAO) Office of Acquisition and Logistics Management (OALM) Hospital and Laboratory Support Division 6701 Rockledge Drive Bethesda, MD 20817

Description

INTRODUCTION

THIS IS A PRE-SOLICITATION NON-COMPETITIVE (NOTICE OF INTENT) SYNOPSIS TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).

The National Institutes of Health (NIH) intends to negotiate and award a contract without providing for full and open competition (Including brand-name) to:

Click to enter vendor address.

NORTH AMERICAN INDUSTRY CLASSIFICATION SYSTEM (NAICS) CODE

The intended procurement is classified under NAICS code 334516 with a Size Standard 1000.

REGULATORY AUTHORITY

The resultant contract will include all applicable provisions and clauses in effect through the Federal Acquisition Circular (FAC) 2005-99-1, July 16, 2018. This acquisition is conducted under the procedures as prescribed in FAR subpart 13-Simplified Acquisition Procedures at an amount not exceeding the simplified acquisition threshold ($350,000).

STATUTORY AUTHORITY

This acquisition is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13-Simplified Acquisition Procedures, Subpart 13.106-1 (b) (1), Soliciting from a single source and is not expected to exceed the simplified acquisition threshold. Contracts awarded using FAR Part 13-Simplified Acquisition Procedures are exempt from the requirements of FAR Part 6-Competition Requirements.

GENERAL INFORMATION

1. Title: Luminex™ xMAP™ INTELLIFLEX System

1. Background Information: The Laboratory of Endocrinology & Receptor Biology at the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) investigates the molecular mechanisms governing thyroid and pituitary function. These studies depend on highly accurate, multiplexed hormone‑measurement assays to reveal how thyroid hormone and related endocrine factors regulate tissue development, signaling pathways, and homeostasis. To maintain scientific rigor, the laboratory requires analytical platforms that deliver exceptional reproducibility, sensitivity, and data integrity. The current Bio-Plex MAGPIX multiplate reader in the laboratory is nonfunctional, outdated, and no longer supported on the market, making it incapable of reliably generating the high‑quality hormone measurement data required for ongoing experiments. This equipment limitation threatens the continuity of critical research, risks data inconsistency, and prevents the lab from carrying out multiplex assays essential for studying thyroid and pituitary regulatory pathways. The laboratory requires a modern, reliable platform capable of sensitive, multiplexed measurement of thyroid and pituitary hormones. A new system will provide the precision, throughput, and reproducibility needed to support ongoing endocrine research. Upgrading the current equipment will ensure consistent data quality and allow experiments to proceed without interruption..

CLOSING STATEMENT

This synopsis is not a request for competitive proposals. However, interested parties may identify their interest and capability to respond to this notice. Responses to this notice shall contain sufficient information to establish the interested parties' bona-fide capabilities for fulfilling the requirement and include a technical proposal, a cost-price proposal, the period of performance, the Unique Entity ID (UEI), the Taxpayer Identification Number (TIN), and the certification of business size. All offerors must have an active registration in the System for Award Management (SAM) www.sam.gov.

A determination by the Government not to compete this proposed contract based upon responses to this notice is solely within the discretion of the Government. The information received will normally be considered solely for the purposes of determining whether to proceed on a non-competitive basis or to conduct a competitive procurement.

All responses must be received by April 20, 2026 at 9:00 AM Eastern time and must reference solicitation number 75N98026Q00189. Responses may be submitted electronically to Mr. James Law, Contracting Officer at James.Law@nih.gov. Fax responses will not be accepted.

"All responsible sources may submit a capability statement, proposal, or quotation, which shall be considered by the agency.”

image1.png